Background: A wider subjective time horizon is assumed to be positively associated with longevity and vitality. In particular, a lifestyle with exposure to novel and varied information is considered beneficial for healthy cognitive aging. At present, measures that specifically assess individuals' perceived temporal extension to engage in active lifestyles in the future are not available. Objectives: We introduce and validate a new self-report measure, the Subjective Health Horizon Questionnaire (SHH-Q). The SHH-Q assesses individuals' future time perspectives in relation to four interrelated but distinct lifestyle dimensions: (1) novelty-oriented exploration (Novelty), (2) bodily fitness (Body), (3) work goals (Work), and (4) goals in life (Life Goals). The present study aims at: (a) validating the hypothesized factor structure of the SHH-Q, according to which the SHH-Q consists of four interrelated but distinct subscales, and (b) testing the hypothesis that the Novelty and Body subscales of the SHH-Q show positive and selective associations with markers of cognition and somatic health, respectively. Methods: Using structural equation modeling, we analyzed data from 1,371 healthy individuals (51% women) with a mean age of 70.1 years (SD = 3.6) who participated in the Berlin Aging Study II (BASE-II) and completed the SHH-Q. Results: As predicted, the SHH-Q formed four correlated but distinct subscales: (1) Novelty, (2) Body, (3) Work, and (4) Life Goals. Greater self-reported future novelty orientation was associated with higher current memory performance, and greater future expectations regarding bodily fitness with better current metabolic status. Conclusion: The SHH-Q reliably assesses individual differences in four distinct dimensions of future time perspective. Two of these dimensions, Novelty and Body, show differential associations with cognitive status and somatic health. The SHH-Q may serve as a tool to assess how different facets of future time perspective relate to somatic health, cognition, motivation, and affect, and may help to identify the socioeconomic and individual antecedents, correlates, and consequences of an active lifestyle.

Keywords:
Successful aging, Novelty-oriented motivation, Exploration, Subjective health horizon, Healthy lifestyle
1.
Rowe JW, Kahn RL: Successful aging 2.0: conceptual expansions for the 21st century. J Gerontol B Psychol Sci Soc Sci 2015;70:593-596.
2.
Hötting K, Holzschneider K, Stenzel A, Wolbers T, Röder B: Effects of a cognitive training on spatial learning and associated functional brain activations. BMC Neurosci 2013;14:73.
3.
Maass A, Düzel S, Goerke M, Becke A, Sobieray U, Neumann K, et al: Vascular hippocampal plasticity after aerobic exercise in older adults. Mol Psychiatry 2015;20:585-593.
4.
Nagamatsu LS, Flicker L, Kramer AF, Voss MW, Erickson KI, Hsu CL, et al: Exercise is medicine, for the body and the brain. Br J Sports Med 2014;48:943-944.
5.
Lövdén M, Wenger E, Mårtensson J, Lindenberger U, Bäckman L: Structural brain plasticity in adult learning and development. Neurosci Biobehav Rev 2013;37:2296-2310.
6.
Nithianantharajah J, Hannan AJ: Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat Rev Neurosci 2006;7:697-709.
7.
van Praag H, Kempermann G, Gage FH: Neural consequences of environmental enrichment. Nat Rev Neurosci 2001;1:191-198.
8.
Düzel E, Bunzeck N, Guitart-Masip M, Düzel S: Novelty-related motivation of anticipation and exploration by dopamine (NOMAD): implications for healthy aging. Neurosci Biobehav Rev 2010;34:660-669.
9.
Lindenberger U: Human cognitive aging: corriger la fortune? Science 2014;346:572-578.
10.
Brandtstädter J, Rothermund K, Kranz D, Kühn W: Final decentrations - personal goals, rationality perspectives, and the awareness of life's finitude. Eur Psychol 2010;15:152-163.
11.
Brandtstädter J, Rothermund K: The life-course dynamics of goal pursuit and goal adjustment: a two-process framework. Dev Rev 2002;22:117-150.
12.
Carstensen L, Lang FR: Future Time Perspective Scale. Stanford, Stanford University, 1996.
13.
Lang FR, Carstensen L: Time counts: future time perspective, goals, and social relationships. Psychol Aging 2002;17:125-139.
14.
Kozik P, Hoppmann CA, Gerstorf D: Future time perspective: opportunities and limitations are differentially associated with subjective well-being and hair cortisol concentration. Gerontology 2015;61:166-174.
15.
Mather M, Carstensen LL: Aging and motivated cognition: the positivity effect in attention and memory. Trends Cogn Sci 2005;9:496-502.
16.
Mather M, Schoeke A: Positive outcomes enhance incidental learning for both younger and older adults. Front Neurosci 2011;5:129.
17.
Gruber MJ, Gelman BD, Ranganath C: States of curiosity modulate hippocampus-dependent learning via the dopaminergic circuit. Neuron 2014;84:486-496.
18.
Lisman J, Grace AA, Duzel E: A neoHebbian framework for episodic memory; role of dopamine-dependent late LTP. Trends Neurosci 2011;34:536-547.
19.
Lisman JE, Grace AA: The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron 2005;46:703-713.
20.
Bollen KA: Structural Equations with Latent Variables. New York, Wiley, 1989.
21.
Mcardle J, Prescott Carol A: Age-based construct validation using structural equation modeling. Exp Aging Res 1992;18:87-115.
22.
Bertram L, Böckenhoff A, Demuth I, Düzel S, Eckardt R, Li S-C, et al: Cohort profile: The Berlin Aging Study II (BASE-II). Int J Epidemiol 2014;43:703-712.
23.
Folstein MF, Robins LN, Helzer JE: The Mini-Mental State Examination. Arch Gen Psychiatry 1983;40:812.
24.
Schmiedek F, Lövdén M, Lindenberger U: Hundred days of cognitive training enhance broad cognitive abilities in adulthood: findings from the COGITO study. Front Aging Neurosci 2010;2:27.
25.
Infurna FJ, Gerstorf D: Linking perceived control, physical activity, and biological health to memory change. Psychol Aging 2013;28:1147-1163.
26.
Szanto O, Montnemery P, Elmstahl S: Prevalence of airway obstruction in the elderly: results from a cross-sectional spirometric study of nine age cohorts between the ages of 60 and 93 years. Prim Care Respir J 2010;19:231-236.
27.
Hill K, Goldstein RS, Guyatt GH, Blouin M, Tan WC, Davis LL, et al: Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ 2010;182:673-678.
28.
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.
29.
Yaffe K: Metabolic syndrome and cognitive disorders: is the sum greater than its parts? Alzheimer Dis Assoc Disord 2007;21:167-171.
30.
Barnes DE, Yaffe K: The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 2011;10:819-828.
31.
Raz N: Diabetes: brain, mind, insulin - what is normal and do we need to know? Nat Rev Endocrinol 2011;7:636-637.
32.
Bender AR, Daugherty AM, Raz N: Vascular risk moderates associations between hippocampal subfield volumes and memory. J Cogn Neurosci 2013;25:1851-1862.
33.
Netz Y, Wu M-J, Becker BJ, Tenenbaum G: Physical activity and psychological well-being in advanced age: a meta-analysis of intervention studies. Psychol Aging 2005;20:272-284.
34.
Muthén LK, Muthén BO: Mplus User's Guide. Los Angeles, Muthén & Muthén, 2010.
35.
Watts AS, Loskutova N, Burns JM, Johnson DK: Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adults. J Alzheimers Dis 2013;35:253-265.
36.
Hassabis D, Maguire EA: Deconstructing episodic memory with construction. Trends Cogn Sci 2007;11:299-306.
37.
Wheeler MA, Stuss DT, Tulving E: Toward a theory of episodic memory: the frontal lobes and autonoetic consciousness. Psychol Bull 1997;121:331-354.
38.
Habib R, McIntosh AR, Wheeler MA, Tulving E: Memory encoding and hippocampally-based novelty/familiarity discrimination networks. Neuropsychologia 2003;41:271-279.
39.
Bird CM, Burgess N: The hippocampus and memory: insights from spatial processing. Nat Rev Neurosci 2008;9:182-194.
40.
Lövdén M, Schaefer S, Noack H, Bodammer NC, Kühn S, Heinze H-J, et al: Spatial navigation training protects the hippocampus against age-related changes during early and late adulthood. Neurobiol Aging 2012;33:620.e9-620.e22.
41.
Nyberg L, Lövdén M, Riklund K, Lindenberger U, Bäckman L: Memory aging and brain maintenance. Trends Cogn Sci 2012;16:292-305.
42.
Maguire EA, Burgess N, Donnett JG, Frackowiak RS, Frith CD, O'Keefe J: Knowing where and getting there: a human navigation network. Science 1998;280:921-924.
43.
Curlik DM, Maeng LY, Agarwal PR, Shors TJ: Physical skill training increases the number of surviving new cells in the adult hippocampus. PLoS One 2013;8:e55850.
44.
Rodrigue KM, Haacke EM, Raz N: Differential effects of age and history of hypertension on regional brain volumes and iron. Neuroimage 2011;54:750-759.
45.
Raz N, Lindenberger U: Life-span plasticity of the brain and cognition: from questions to evidence and back. Neurosci Biobehav Rev 2013;37:2195-2200.
46.
Hedden T, Gabrieli JD: Healthy and pathological processes in adult development: new evidence from neuroimaging of the aging brain. Curr Opin Neurol 2005;18:740-747.
47.
Raz N: Decline and compensation in aging brain and cognition: promises and constraints. Preface. Neuropsychol Rev 2009;19:411-414.
48.
Lachman ME, Agrigoroaei S: Promoting functional health in midlife and old age: long-term protective effects of control beliefs, social support, and physical exercise. PLoS One 2010;5:e13297.
49.
Heckhausen J, Wrosch C, Schulz R: A motivational theory of life-span development. Psychol Rev 2010;117:32-60.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.